Activation of cc-adrenoceptors (ARs) results in an influx of calcium that is independent from the voltage-gated calcium ion channel

M. L. Earle, W. C. Cole, Christopher Triggle

Research output: Contribution to journalArticle

Abstract

In vascular smooth muscle, activation of the a-AR results in an initial transient IPS-mediated increase in Ca2+i followed by a sustained influx of Ca2+e. Several studies suggest these effects are mediated in part via a G protein, most likely Gq (Garcia-Sâinz, 1993). FURA-2 measurements of global Ca2+ in isolated smooth muscle cells from the rat tail artery suggest that this influx pathway is insensitive to nifedipine. Experiments to test this hypothesis utilizing the perforated patch clamp technique and global Ca2+ measurements with FURA-2 in freshly dispersed vascular smooth muscle cells of the rat tail artery demonstrate that Ba2+ currents were reversibly inhibited in the presence of an a-AR agonist, cirazoline. Net current recordings at a holding potential of -40 mV, close to the resting membrane potential of these cells, demonstrate the presence of a nifedipine-insensitive inward current following application of the pAR agonist phenylephrine, which is preceded by activation of spontaneous transient outward currents (STOCs), carried by the Ca2+ -activated potassium channels. We attempted to clarify the identity of this influx pathway by direct actuation of the G proteins with NaF, which produced a similar influx of Ca2+e (FURA-2) and an associated inward current in the absence of the a-AR. We propose that following activation of the a-AR and the concomitant activation of Gq, elevation of global Ca2+ is the result of both intracellular release and VGCC-independent influx of Ca2+, perhaps via the non-selective cation channel. A local subsarcolemmal rise in Ca2+ is implied by activation of STOCs and most likely accounts for the inhibition of the Ba2+ current.

Original languageEnglish
Pages (from-to)155
Number of pages1
JournalProceedings of the Western Pharmacology Society
Volume40
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Calcium Channels
Adrenergic Receptors
Calcium
Nifedipine
Vascular Smooth Muscle
GTP-Binding Proteins
Smooth Muscle Myocytes
Tail
Arteries
Potassium Channels
Phenylephrine
Patch-Clamp Techniques
Membrane Potentials
Cations

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{8d97c662e38b430095b70e9a5771a257,
title = "Activation of cc-adrenoceptors (ARs) results in an influx of calcium that is independent from the voltage-gated calcium ion channel",
abstract = "In vascular smooth muscle, activation of the a-AR results in an initial transient IPS-mediated increase in Ca2+i followed by a sustained influx of Ca2+e. Several studies suggest these effects are mediated in part via a G protein, most likely Gq (Garcia-S{\^a}inz, 1993). FURA-2 measurements of global Ca2+ in isolated smooth muscle cells from the rat tail artery suggest that this influx pathway is insensitive to nifedipine. Experiments to test this hypothesis utilizing the perforated patch clamp technique and global Ca2+ measurements with FURA-2 in freshly dispersed vascular smooth muscle cells of the rat tail artery demonstrate that Ba2+ currents were reversibly inhibited in the presence of an a-AR agonist, cirazoline. Net current recordings at a holding potential of -40 mV, close to the resting membrane potential of these cells, demonstrate the presence of a nifedipine-insensitive inward current following application of the pAR agonist phenylephrine, which is preceded by activation of spontaneous transient outward currents (STOCs), carried by the Ca2+ -activated potassium channels. We attempted to clarify the identity of this influx pathway by direct actuation of the G proteins with NaF, which produced a similar influx of Ca2+e (FURA-2) and an associated inward current in the absence of the a-AR. We propose that following activation of the a-AR and the concomitant activation of Gq, elevation of global Ca2+ is the result of both intracellular release and VGCC-independent influx of Ca2+, perhaps via the non-selective cation channel. A local subsarcolemmal rise in Ca2+ is implied by activation of STOCs and most likely accounts for the inhibition of the Ba2+ current.",
author = "Earle, {M. L.} and Cole, {W. C.} and Christopher Triggle",
year = "1997",
language = "English",
volume = "40",
pages = "155",
journal = "Proceedings of the Western Pharmacology Society",
issn = "0083-8969",
publisher = "Western Pharmacology Society",

}

TY - JOUR

T1 - Activation of cc-adrenoceptors (ARs) results in an influx of calcium that is independent from the voltage-gated calcium ion channel

AU - Earle, M. L.

AU - Cole, W. C.

AU - Triggle, Christopher

PY - 1997

Y1 - 1997

N2 - In vascular smooth muscle, activation of the a-AR results in an initial transient IPS-mediated increase in Ca2+i followed by a sustained influx of Ca2+e. Several studies suggest these effects are mediated in part via a G protein, most likely Gq (Garcia-Sâinz, 1993). FURA-2 measurements of global Ca2+ in isolated smooth muscle cells from the rat tail artery suggest that this influx pathway is insensitive to nifedipine. Experiments to test this hypothesis utilizing the perforated patch clamp technique and global Ca2+ measurements with FURA-2 in freshly dispersed vascular smooth muscle cells of the rat tail artery demonstrate that Ba2+ currents were reversibly inhibited in the presence of an a-AR agonist, cirazoline. Net current recordings at a holding potential of -40 mV, close to the resting membrane potential of these cells, demonstrate the presence of a nifedipine-insensitive inward current following application of the pAR agonist phenylephrine, which is preceded by activation of spontaneous transient outward currents (STOCs), carried by the Ca2+ -activated potassium channels. We attempted to clarify the identity of this influx pathway by direct actuation of the G proteins with NaF, which produced a similar influx of Ca2+e (FURA-2) and an associated inward current in the absence of the a-AR. We propose that following activation of the a-AR and the concomitant activation of Gq, elevation of global Ca2+ is the result of both intracellular release and VGCC-independent influx of Ca2+, perhaps via the non-selective cation channel. A local subsarcolemmal rise in Ca2+ is implied by activation of STOCs and most likely accounts for the inhibition of the Ba2+ current.

AB - In vascular smooth muscle, activation of the a-AR results in an initial transient IPS-mediated increase in Ca2+i followed by a sustained influx of Ca2+e. Several studies suggest these effects are mediated in part via a G protein, most likely Gq (Garcia-Sâinz, 1993). FURA-2 measurements of global Ca2+ in isolated smooth muscle cells from the rat tail artery suggest that this influx pathway is insensitive to nifedipine. Experiments to test this hypothesis utilizing the perforated patch clamp technique and global Ca2+ measurements with FURA-2 in freshly dispersed vascular smooth muscle cells of the rat tail artery demonstrate that Ba2+ currents were reversibly inhibited in the presence of an a-AR agonist, cirazoline. Net current recordings at a holding potential of -40 mV, close to the resting membrane potential of these cells, demonstrate the presence of a nifedipine-insensitive inward current following application of the pAR agonist phenylephrine, which is preceded by activation of spontaneous transient outward currents (STOCs), carried by the Ca2+ -activated potassium channels. We attempted to clarify the identity of this influx pathway by direct actuation of the G proteins with NaF, which produced a similar influx of Ca2+e (FURA-2) and an associated inward current in the absence of the a-AR. We propose that following activation of the a-AR and the concomitant activation of Gq, elevation of global Ca2+ is the result of both intracellular release and VGCC-independent influx of Ca2+, perhaps via the non-selective cation channel. A local subsarcolemmal rise in Ca2+ is implied by activation of STOCs and most likely accounts for the inhibition of the Ba2+ current.

UR - http://www.scopus.com/inward/record.url?scp=33748140358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748140358&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 155

JO - Proceedings of the Western Pharmacology Society

JF - Proceedings of the Western Pharmacology Society

SN - 0083-8969

ER -